纯腹腔镜与开腹肝切除治疗肝细胞癌的长期围手术期结局:回顾性研究
该回顾性研究纳入2007年7月至2016年4月单中心2335例肝细胞癌肝切除患者,经1:2倾向性评分匹配后比较腹腔镜(217例)与开腹(434例)肝切除。腹腔镜组住院更短、术后并发症更低,1、3、5年总生存率和无病生存率两组无显著差异。
要点
- 匹配后腹腔镜组住院8.9天 vs 开腹14.8天,术后并发症6.5% vs 12.0%。
- 两组1、3、5年总生存率与无病生存率均无显著差异。
- 经验丰富术者对选定患者行腹腔镜肝切除安全可行。
核心结论
- 对选定患者,腹腔镜与开腹肝切除的长期肿瘤学结局相当。
- 腹腔镜肝切除具有住院更短和术后并发症更低的优势。
研究设计与样本
- 单中心回顾性研究,纳入2007年7月至2016年4月肝细胞癌肝切除患者共2335例。
- 分为腹腔镜组264例和开腹组2071例,采用1:2倾向性评分匹配比较。
- 匹配后腹腔镜组217例,开腹组434例。
主要发现
- 腹腔镜组住院时间8.9天,开腹组14.8天(P < 0.001)。
- 腹腔镜组术后并发症发生率6.5%,开腹组12.0%(P = 0.022)。
- 腹腔镜组1、3、5年总生存率分别为98.1%、87.0%、78.6%,开腹组分别为98.3%、90.8%、84.3%(P = 0.570)。
- 腹腔镜组1、3、5年无病生存率分别为81.0%、62.0%、49.1%,开腹组分别为85.3%、64.7%、56.2%(P = 0.563)。
临床怎么用
- 对选定肝细胞癌患者,经验丰富术者可考虑将腹腔镜肝切除作为开腹肝切除的替代方案。
- 腹腔镜肝切除可能缩短住院时间并降低术后并发症。
局限性
- 本研究为单中心回顾性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laparoscopic treatment for hepatocellular carcinoma (HCC) has increased. We retrospectively compared the perioperative and long-term oncological outcomes of laparoscopic liver resection (LLR) with those of open liver resection (OLR) for hepatocellular carcinoma (HCC) in well-matched patient groups using propensity score matching (PSM). METHODS: We reviewed medical records of patients with HCC who underwent liver resection between July 2007 and April 2016 at our center. In total, 2335 patients were included in this study and divided into LLR (n = 264) and OLR (n = 2071) groups. For group comparisons, 1:2 PSM was used with covariates of baseline characteristics, including tumor characteristics and surgical liver resection procedures. RESULTS: After PSM, there were 217 and 434 patients in the LLR and OLR groups, respectively. The LLR group had shorter hospital stays (8.9 vs. 14.8 days; P < 0.001) and lower postoperative morbidity (6.5% vs. 12.0%; P = 0.022). The 1-, 3-, and 5-year overall survival rates were 98.1%, 87.0%, and 78.6%, respectively, for the LLR group, and 98.3%, 90.8%, and 84.3%, respectively, for the OLR group (P = 0.570). The 1-, 3-, and 5-year disease-free survival rates were 81.0%, 62.0%, and 49.1%, respectively, for the LLR group, and 85.3%, 64.7%, and 56.2%, respectively, for the OLR group (P = 0.563). CONCLUSIONS: Long-term oncological outcomes were comparable between LLR and OLR for selected patients. LLR was associated with multiple benefits, even for selected patients with cirrhosis who underwent major hepatectomy. LLR for HCC performed by an experienced surgeon could be considered a safe and feasible alternative to OLR for selected patients.
引用
- Yoon YI, Kim KH, Cho HD, et al. Long-term perioperative outcomes of pure laparoscopic liver resection versus open liver resection for hepatocellular carcinoma: a retrospective study. Surg Endosc. 2019. PMID: 31161292. doi:10.1007/s00464-019-06831-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。